NCT04261712 - A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions

Acromegaly

Interventions

DRUG

Paltusotine

Paltusotine, once daily by mouth

Trial Locations (21)

1062

Crinetics Study Site, Budapest

1083

Crinetics Study Site, Budapest

7624

Crinetics Study Site, Pécs

10676

Crinetics Study Site, Athens

11000

Crinetics Study Site, Belgrade

11527

Crinetics Study Site 1, Athens

Crinetics Study Site 2, Athens

15212

Crinetics Study Site, Pittsburgh

15213

Crinetics Study Site, Pittsburgh

20231

Crinetics Study Site, Rio de Janeiro

21941

Crinetics Study Site, Rio de Janeiro

43210

Crinetics Study Site, Columbus

54642

Crinetics Study Site, Thessaloniki

60611

Crinetics Study Site, Chicago

75231

Crinetics Study Site, Dallas

90095

Crinetics Study Site, Los Angeles

02114

Crinetics Study Site, Boston

80030-110

Crinetics Study Site, Curitiba

01228

Crinetics Study Site, São Paulo

Unknown

Crinetics Study Site, Coventry

LS97TF

Crinetics Study Site, Leeds